Prediabetic, overweight men with hypogonadism show improvements in testosterone levels after lifestyle modifications consisting of calorie and fat reductions and exercise….
Read More »Diabetes In Control
Diabetes Patients’ Use of Aspirin May Not Be Effective
Many patients with type 2 diabetes may be aspirin resistant and a standard aspirin dose may not protect them against blood clots that can cause heart attacks and strokes….
Read More »New Research Finds That Not All Calories Are the Same
The statement that “all foods can be part of a healthful diet as long as you watch calories … is really misleading”….
Read More »More On Coffee: Good or Bad?
New research from the U.S. contradicts the American Heart Association that currently warns against regular coffee consumption….
Read More »Hypoglycemia Prevented by New Insulin
An experimental insulin drug prevented low blood sugar among diabetic patients more often than insulins now available….
Read More »Physical Fitness Improves Survival among Diabetes Patients with Heart Dysfunction
Being physically fit may improve survival rates among diabetes patients with a particular type of heart abnormality….
Read More »Insulin with Liraglutide Improves Poorly Controlled Type 1
Obese adults with poorly controlled type 1 diabetes can better control their blood sugar by adding liraglutide to their insulin therapy….
Read More »Weight Loss Aided in Diabetic Patients by Experimental Drug
An experimental drug helped significantly more overweight patients with diabetes shed pounds, compared with placebo….
Read More »Sitagliptin Improves Reactive Hypoglycemia Symptoms
The diabetes drug sitagliptin appears to reduce the severity of reactive hypoglycemia….
Read More »FDA Approves New Weight-Loss Drug
FDA Approves New Weight-Loss Drug The oral weight-loss drug lorcaserin hydrochloride (Belviq) has been approved as an adjunct to diet and exercise in obese patients as well as in those who are overweight and have at least one other weight-related disorder such as hypertension. See this week’s Item #2, FDA …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.